DNTH Dianthus Therapeutics, Inc. /DE/
NEUTRAL
Impact: 3/10
8-K
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Final — all horizons settled through T+60d ⚠ clustered
DNTH ▲ +0.24% at T+60d
NEUTRAL call ✓ call won +0.24% · α vs SPY -10.46% · entry $80.32 → $80.51
Last close $81.22 (close Jun 8) · +1.12% from $80.32 entry
T+1d
-3.06%
call -3.06% · α -2.47%
$77.86
settled 3mo ago
T+5d
-0.40%
call -0.40% · α +0.58%
$80.00
settled 3mo ago
T+20d
+11.77%
call +11.77% · α +9.79%
$89.77
settled 2mo ago
T+60d
+0.24%
call +0.24% · α -10.46%
$80.51
settled yesterday
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits), suggesting Dianthus Therapeutics may have entered a significant agreement, but no details are accessible to confirm nature or terms.
Actionable Insight
Monitor for public disclosure or press release from Dianthus Therapeutics regarding the nature of the agreement. Absence of financial details limits immediate trading implications.
Key Facts
- Filing is Form 8-K with Items 1.01 and 9.01 reported.
- Item 1.01 indicates a material definitive agreement may have been entered into.
- Item 9.01 suggests financial statements or exhibits were filed, possibly related to the agreement.
- No document content available to verify agreement type, parties, or financial terms.
Financial Impact
Not specified
Risk Factors
- Material agreement could involve dilution, contingent payments, or strategic shift not currently quantifiable.
- Lack of accessible filing content increases information asymmetry risk.
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
Report based on filing metadata.
8 reports for DNTH
75%
Hit rate
best @ T+1▲ +9.71%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 5, 2026
5w ago
|
8-K
| $90.42 $84.97 | ▼ −6.03% | ▼ −8.81% | $81.22 (−10.17%) |
|
Mar 12, 2026
12w ago
|
Press Release
| $77.86 $90.00 | ▲ +15.59% | ▲ +12.00% | $81.22 (+4.32%) |
|
Mar 12, 2026
12w ago
|
8-K
| $80.32 $89.77 | ▲ +11.77% | ▲ +9.79% | $81.22 (+1.12%) |
|
Mar 12, 2026
12w ago
|
Insider Cluster
| $80.32 $89.77 | ▼ −11.77% | ▼ −9.79% | $81.22 (−1.12%) |
|
Mar 12, 2026
12w ago
|
Insider Cluster
| $80.32 $89.77 | ▼ −11.77% | ▼ −9.79% | $81.22 (−1.12%) |
|
Mar 11, 2026
13w ago
|
Press Release
| $85.84 $91.66 | ▲ +6.78% | ▲ +6.26% | $81.22 (−5.38%) |
|
Mar 9, 2026
13w ago
|
Press Release
| $79.23 $86.20 | ▲ +8.80% | ▲ +11.60% | $81.22 (+2.51%) |
|
Mar 8, 2026
13w ago
|
Press Release
| $79.23 $86.20 | ▲ +8.80% | ▲ +11.60% | $81.22 (+2.51%) |
Showing 8 of 8
US Market Status
Market Closed — Opens in 8h 33m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access